Hypercortisolemia, hippocampal glucocorticoid receptors, and fast feedback

Molecular Psychiatry

Volumn 1, Issue 2, 1996, Pages 149-159

  Young, E A ^a   Vazquez, D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Aging; Alzheimer's; Depression; DST; Hypothalamic pituitary adrenal axis; Stress

Indexed keywords

GLUCOCORTICOID RECEPTOR; HYDROCORTISONE;

BLOOD; FEEDBACK SYSTEM; HIPPOCAMPUS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

FEEDBACK; HIPPOCAMPUS; HUMANS; HYDROCORTISONE; RECEPTORS, GLUCOCORTICOID;

EID: 0030133292     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Seeman TE, Robbins RJ. Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocrine Rev 1994; 15: 233-260.
2. Keller-Wood ME, Dallman MF. Corticosteroid inhibition of ACTH secretion. Endocrine Rev 1985; 5: 1-24.
3. Jones MT, Brush FR, Neame RLB. Characteristics of fast feedback control of corticotrophin release by corticosteroids. J Endocrinol 1972; 55: 489.
4. Dallman MF, Yates FE. Dynamic asymmetries in the corticosteroid feedback path and distribution-metabolism-binding elements of adrenocortical system. Ann NY Acad Sci 1969; 156: 696.
5. Jones MT, Hillhouse EW. Structure-activity relationship and the mode of action of corticosteroid feedback on the secretion of corticotropin releasing factor (corticoliberin). J Steroid Biochem 1976; 7: 1189-1200.
6. Hillhouse EW, Jones MT. Effect of bilateral adrenalectomy and corticosteroid therapy on the secretion of corticotrophin-releasing factor activity from the hypothalamus of the rat in vitro. J Endocrinol 1976; 71: 21-30.
7. Jones MT, Tiptaft EM, Brush FR, Fergusson DAN, Neame RLB. Evidence for dual corticosterone receptor mechanism in the control of adrenocorticotrophin secretion. J Endocrinol 1974; 60: 223.
8. Dallman MF, Akana SF, Cascio ES, Darlington DN, Jacobson L, Levin N. Regulation of ACTH secretion: variations on a theme of B. Recent Prog Hormone Res 1987; 43: 113-173.
9. Russell SM, Dhariwal APS, McCann SM, Yates FE. Inhibition by dexamethasone of the in vitro pituitary response to corticotropin-releasing factor. Endocrinology 1969; 85: 512.
10. Schacter BS, Johnson LK, Baxter JD, Roberts JL. Differential regulation by glucocorticoids of proopiomelanocortin mRNA levels in the anterior and intermediate lobes of the rat pituitary. Endocrinology 1982; 110: 1142.
11. Birnberg NC, Civelli O, Lissitzski JC, Hinman M, Herbert E. Regulation of pro-opiomelanocortin gene expression in the pituitary and central nervous system. Endocrinology 1982; 110: 134A.
12. Dayanithi G, Antoni FA. Rapid as well as delayed inhibitory effects of glucocorticoid hormones on pituitary adrenocorticotropic hormone release are mediated by Type II glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as well as protein. Endocrinology 1989; 125: 308-313.
13. Roberts JL, Budarf ML, Baxter JD, Herbert E. Selective reduction of proadrenocorticotropin/endorphin proteins and messenger ribonucleic acid activity in mouse pituitary tumor cells by glucocorticoids. Biochemistry 1979; 22: 4907-4915.
14. Jingami H, Matsukura S, Numa S, Imura H. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/β-lipotropin precursor mRNA in the pituitary rats. Endocrinology 1985; 117: 1314-1320.
15. Kovacs K, Makara GB. Corticosterone and dexamethasone act at different sites to inhibit adrenalectomy induced adrenocorticotropin hypersection. Brain Res 1988; 474: 205-210.
16. Young EA, Akil H. CRF stimulation of ACTH/beta-endorphin release: effect of acute and chronic stress. Endocrinology 1985; 117: 23-30.
17. Childs GV, Morell JL, Niendorf A, Aguilera G. Cytochemical studies of Corticotropin Releasing Factor receptors in anterior lobe corticotrophs: binding, glucocorticoid regulation and endocytosis of [Biotinyl-Serl] CRF. Endocrinology 1986; 119: 2129.
18. Schwartz J, Billestrup N, Perrin M, Rivier J, Vale W. Identification of Corticotropin Releasing Factor target cells and effects of dexamethasone on binding in anterior pituitary using a fluorescent analog of CRF. Endocrinology 1986; 119: 2376.
19. Widmaier EP, Dallman MF. Rapid inhibition and stimulation of ACTH by glucocorticoids in vitro. Fed Proc 1983; 42: 458.
20. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocrinology Rev 1986; 7: 284-301.
21. Feldman S, Conforti N. Participation of the dorsal hippocampus in glucocorticoid negative feedback effect on adrenocortical activity. Neuroendocrinology 1980; 30: 52-55.
22. Herman JP, Schafer MK-H, Young EA, Thompson RC, Douglas JO, Akil H, Watson SJ. Hippocampal regulation of the hypothalamo-pituitary-adrenocortical axis: in situ hybridization analysis of CRF and vasopressin messenger RNA expression in the hypothalamic paraventricular nucleus following hippocampectomy. J Neuroscience 1989; 9: 3072-3082.
23. Herman JP, Cullinan WE, Young EA, Akil H, Watson SJ. Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) mRNA expression. Brain Res 1992; 592: 228-238.
24. Herman JP, Cullinan WE, Watson SJ. Involvement of the bed nucleus of the stria terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA expression. J Neuroendocrinol 1994; 6: 433-442.
25. Cullinan WE, Herman JP, Watson SJ. Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. J Comp Neurol 1993; 332: 1-20.
26. Makara GB, Stark E. Effect of gamma-aminobutyric (GABA) and GABA antagonist drugs on ACTH release. Neuroendocrinology 1974; 16: 178-190.
27. Acs Z, Stark E. Possible role of gamma-aminobutyric: acid synthesis in the mechanism of doxamethasone feedback action. Endocrinology 1978; 77: 137-141.
28. Tappaz ML, Brownstein MJ. Origin of glutamato-decarboxylase (GAD)-containing cells in discrete hypothalamic nuclei. Brain Res 1982; 132: 95-106.
29. Plotsky PM, Otto S, Sutton S. Neurotransmitter modulation of corticotropin releasing factor secretion into the hypophysial-portal circulation. Life Sci 1987; 41: 1311-1317.
30. Calogoro AE, Gallucci WT, Chrousos GP, Gold PW. Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res 1988; 463: 28-36.
31. Herman JP, Cullinan WE, Morano MI, Akil H, Watson SJ. Contribution of the ventral subiculum to inhibitory regulation of the hypothalamo-pituitary-adrenocortical axis. J Neuroendocrinology 1995; 7: 475-482.
32. Bradbury MJ, Strack AM, Dallman MF. Lesions of the hippocampal efferent pathway (fimbria-fornix) do not alter sensitivity of adrenocorticotropin to feedback inhibition by corticosterone in rats. Neuroendocrinology 1993; 58: 396-407.
33. Parnetti L, Mococci P, Neri C, Palazzetti D, Fiacconi M, Santucci A, Santucci G, Ballatori E, Roboldi GP, Caputo N et al. Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test. Aging 1990; 2: 173-179.
34. Lawlor BA, Tsuboyama G, Ryan T, Mohs RG, Davis BM, Davidson M, Gabriel S, Davis KL. Agitation and post-dexamethasone cortisol levels in Alzheimer's disease. Am J Psychiatry 1992; 149: 546-548.
35. Groonwald BS, Mathe AA, Mohs RC, Levy MI, Johns CA, Davis KL, Cortisol and Alzheimer's disease. II: dexamethasone suppression, dementia severity, and affective symptoms. Am J Psychiatry 1986; 143: 442-440.
36. Davis KL, Davis BM, Greenwald BS, Mohs RC, Mathe AA, Johns CA, Horvath TB. Cortisol and Alzheimer's disease. 1: basal studies. Am J Psychiatry 1986; 143: 300-305.
37. Raskind M, Peskind E, Rivard MF, Veith R, Barnes R. Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia. Am J Psychiatry 1982; 139: 1468-1471.
38. Ferrier IN, Pascual J, Charlton BG, Wright G, Leake A, Griffiths HW, Fairbairn AF, Edwardson JA, Cortisol, ACTH, and dexamethasone concentrations in a psychogeriatric population. Biol Psychiatry 1988; 23: 252-260.
39. Shrimankar J, Soni SD, McMurray J. Dexamethasone suppression test in dementia and depression. Clinical and biological correlates. Br J Psychiatry 1989; 154: 372-377.
40. De Leo D, Schifano F, Magni G. Results of dexamethasone suppression test in early Alzheimer dementia. Eur Arch Psychiatry Neurol Sci 1988: 238: 19-21.
41. Jenike MA, Albert MS. The dexamethasone suppression test in patients with presenile and senile dementia of the Alzheimer's type. J Am Gariatr Soc 1984; 32: 441-444.
42. Miller AH, Sastry G, Speranza AJ Jr, Lawlor BA, Mohs KG, Ryan TM, Gabriel SM, Serby M, Schmeidler J, Davis KL. Lack of association between cortisol hypersecretion and nonsuppression on the DST in patients with Alzheimer's disease. Am J Psychiatry 1994; 151: 267-270.
43. Nasman B, Olsson T, Viitanen M, Carlstrom K. A subtle disturbance in the feedback regulation of the hypothalamic-pituitary-adrenal axis in the early phase of Alzheimer's disease. Psychoneuroendocrinology 1995; 20: 211-220.
44. Molchan SE, Hill JL, Mellow AM, Lawlor BA, Martinez R, Sunderland T. The dexamethasone suppression test in Alzheimer's disease and major depression: relationship to dementia severity, depression, and CSF monoamines. Int Psychogeriatr 1990; 2: 99-122.
45. Gurevich D, Siegel B, Dumlao M, Perl E, Chaitin P, Bagne C, Oxenkrug G. HPA axis responsivity to dexamethasone and cognitive impairment in dementia. Prog Neuropsychopharmacol Biol Psychiatry 1990; 41: 297-308.
46. Oxenkrug GF, Gurevich D, Siegel B, Dumlao MS, Gershon S. Correlation between brain-adrenal axis activation and cognitive impairment in Alzheimer's disease: is there a gender effect? Psychiatry Res 1989; 29: 169-175.
47. Issa AM, Rowe W, Meaney MJ. Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats. J Neuroscience 1990; 10: 3247-3254.
48. Dodt C, Dittman J, Hruby J, Spath-Schwalbe E, Born J, Schuttler R, Fehm H. Different regulation of ACTH and cortisol secretion in young, mentally healthy elderly and patients with senile dementia of Alzheimer's type. JCEM 1991; 72: 272-276.
49. Hatzinger M, Z'Brun A, Hemmeter U, Seifritz E, Baumann F, Holsboer-Trachsler E, Heuser IJ. Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease. Neurobiol Aging 1995; 16: 205-209.
50. O'Brien JT, Schweitzer I, Ames D, Mastwyk M, Colman P. The function of the hypothalamic-pituitary-adrenal axis in Alzheimer's disease. Response to insulin hypoglycaemia. Br J Psychiatry 1994; 165: 650-657.
51. McEwen BS, Weiss JM, Schwartz LS. Selective retention of corticosterone by limbic structures in the rat brain. Nature 1968; 220: 911.
52. McEwen BS, Weiss JM, Scwartz LS. Retention of corticosterone by cell nuclei from brain regions of adrenalectomized rats. Brain Res 1970; 17: 471.
53. deKloet R, Wallach G, McEwen BS. Differences in corticosterone and dexamethasone binding to rat brain and pituitary. Endocrinology 1975; 96: 598.
54. Sapolsky RM, Meaney MJ. Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res Rev 1986; 11: 65-76.
55. Walker CD, Sapolsky RM, Meaney MJ, Vale WW, Rivier CL. Increased pituitary sensitivity to glucocorticoid feedback during the stress nonresponsive period in the neonatal rat. Endocrinology 1986; 119: 1816-1821.
56. Walker CD, Perrin M, Vale WW, Rivier CL. Ontogeny of the stress response in the rat: role of the pituitary and hypothalamus. Endocrinology 1986; 118: 1445-1455.
57. Do Kloet ER, Rosenfeld P, Van Eekelen AM, Sutanto W, Levine S. Stress, glucocorticoids and development. Progress Brain Res 1988; 73: 101-120.
58. Goldman L, Winget C, Hollingshead GH, Levine S. Postweaning development of negative feedback in the pituitary-adrenal system of the rat. Neuroendocrinology 1978; 12: 188-211.
59. Vazquez DM, Akil H. Pituitary-adrenal response to ether vapor in the weanling animal: characterization of the inhibitory effect of glucocorticoids on adrenocorticotropin secretion. Pediatric Res 1993; 34: 646-653.
60. Gould E, Woolley CS, Cameron HA, Daniels DC, McEwen BS. Adrenal steroids regulate postnatal development of the rat dentate gyrus. II. Effects of glucocorticoids and mineralocorticoids on cell birth. J Comp Neurol 1991; 313: 486-493.
61. Seress L, Frotscher M, Ribak CE. Local circuit neurons in both the dentate gyms and Ammon's horn establish synaptic connections with principal neurons in both the dentate gyrus and morphological basis for inhibition in early development. Exp Brain Res 1989; 78: 1-9.
62. Nyakas C, Luiten PG, Traber J. Detailed projection patterns of septal and diagonal band efferents to the hippocampus in the rat with emphasis on innervation of CA1 and dentate gyrus. Brain Res Bull 1987; 4: 533-545.
63. Riegle GD. Chronic stress effects on adrenocortical responsiveness in young and aged rats. Neuroendocrinology 1973; 11: 1-10.
64. Landfield PW, Waymire JC, Lynch G. Hippocampal aging and adrenocorticoids: quantitative correlations. Science 1978; 202: 1098-1101.
65. Tang F, Phillips JG. Some age related changes in pituitary-adrenal function in the male laboratory rat. J Gerontol 1978; 33: 377-382.
66. Sapolsky RM, Krey LC, McEwen BS. The adrenocortical stress response in the aged male rat: impairment of recovery from stress. Exper Gerontol 1983; 18: 55-64.
67. DeKosky S, Scheff S, Cotman C. Elevated corticosterone levels: a mechanism for impaired sprouting in the aged hippocampus. Neuroendocrinology 1984; 38: 33-40.
68. Oxenkrug GF, McIntyre IM, Stanley M, Gershon S. Dexamethasone suppression test: experimental animal models in rats and effects of age. Biol Psychiatry 1984; 19: 413-416.
69. Morano M, Vazquez D, Akil H. The role of the hippocampal mineralocorticoid and glucocorticoid receptors in the hypothalamo-pituitary-adrenal axis of the aged Fisher rat. Mol Cell Neurosci 1994; 5: 400-412.
70. McEwen BS, Gould EA, Sakai RR. The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress. Br J Psychiatry Suppl 1992; 15: 18-23.
71. Watanabe Y, Gould E, Daniels DC, Cameron H, McEwen BS. Tianeptine attenuates stress-induced morphological changes in the hippocampus. Eur J Pharmacol 1992; 222: 157-162.
72. Sloviter RS, Valiquette G, Abrams GM, Ronk EC, Sollas AL, Paul LA, Neubort S. Selective loss of hippocampal granule cells in the mature rat brain after adrenalectomy. Science 1989; 243: 535-538.
73. Gould E, Cameron HA, Daniels DC, Woolley CS, McEwen BS. Adrenal hormones suppress cell division in the adult rat dentate gyrus. J Neuroscience 1992; 12: 3642-3650.
74. Spencer RL, Miller AH, Stein M, McEwen BS. Corticosterone regulation of type I and type II adrenal steroid receptors in brain, pituitary, and immune tissue. Brain Res 1991; 549: 236-246.
75. Akana SF, Scribner KA, Bradbury MJ, Strack AM, Walker CD, Dallman MF. Feedback sensitivity of the rat hypothalamo-pituitary-adrenal axis and its capacity to adjust to exogenous corticosterone. Endocrinology 1992; 131: 585-594.
76. Young EA, Kwak SP, Kottak J. Negative feedback regulation following administration of chronic exogenous corticosterone. J Neuroendocrinology 1995; 7: 37-45.
77. Young EA. Normal glucocorticoid fast feedback following chronic 50% corticosterone pellet treatment. Psychoneuroendocrinology 1995; 20: 771-784.
78. Young EA, Akana S, Dallman MF. Decreased sensitivity to glucocorticoid fast feedback in chronically stressed rats. Neuroendocrinology 1990; 51: 536-542.
79. Sapolsky RM, Krey LC, McEwen BS. Stress down-regulates glucocorticoid receptors in a site-specific manner. Endocrinology 1984; 114: 287-292.
80. Meaney MJ, Aitken DH, Viau V, Sharma S, Sarrieau A. Neonatal handling alters adrenocortical negative feedback sensitivity and hippocampal type II glucocorticoid receptor binding in the rat. Neuroendocrinology 1988; 50: 597-604.
81. Young EA, Haskett RF, Watson SJ, Akil H. Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry 1991; 48: 693-699.
82. Coffey CE, Wilkinson WE, Weiner RD, Parashos IA, Djang WT, Webb MC, Figiel GS, Spritzer CE. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Arch Gen Psychiatry 1993; 50: 7-16.
83. Axelson DA, Doraiswamy PM, McDonald WM, Boyko OB, Tupler LA, Patterson LJ, Nemeroff CB, Ellinwood EH Jr, Krishnan KR. Hypercortisolemia and hippocampal changes in depression. Psychiatry Res 1993; 47: 163-173.
84. O'Brien JT, Desmond P, Ames D, Schweitzer I, Tuckwell V, Tress B. The differentiation of depression from dementia by temporal lobe magnetic resonance imaging. Psychol Med 1994; 24: 633-640.
85. Starkman MN, Gebarski SS, Borent S, Schteingart DE. Hippocampal formation volume, memory dysfunction and cortisol levels in patients with Cushing's syndrome. Biol Psych 1992; 32: 756-765.
86. Daly JR, Reader SCJ, Alaghband J, Haisman P. Observation of feedback regulation of corticotropin (ACTH) secretion in man. In: Jones MT, Dallman MF, Gillham B, Chattopadhay S (eds). Interaction Within the Brain-Pituitary-Adrenocortical System. Academic Press: Orlando, FL, 1979.
87. Fehn FL, Voight KH, Kummer K, Lang R, Pfeiffer OF. Positive rate sensitive corticosteroid feedback mechanism of ACTH secretion in Cushing's disease. J Clin Invest 1979; 64: 102-108.